Children with higher cardiorespiratory and muscular fitness and a lower waist-to-hip ratio had higher scores in cognitive tests for attention and processing speed during middle age.
Older adults who live in more affluent areas have better memories and a lower risk of developing Alzheimer's disease than those who live in less affluent areas.
Study reveals how an enzyme called NOX4 is essential for exercise-induced reactive oxygen species and the adaptive response that drives metabolic health.
More time spent outside in natural light was associated with improved mood, better sleep quality, and ease of waking.
Humorous interventions and conversations could be effective ways to influence people's behavior and intentions surrounding their health.
Researchers report essential oils may help improve mood and symptoms in those with anxiety and depression due to anti-oxidant effects on the brain.
An ancient Aboriginal memorization technique has been proven to be superior to the ancient Greek "memory palace" technique when it came to recalling and retaining factual information people had learned.
Severe obstructive sleep apnea is linked to an increase of the amyloid beta protein, resulting in a greater risk of sufferers developing dementia.
Women who have been pregnant were diagnosed with their first multiple sclerosis symptoms, on average, 3.3 years later than women with MS who had never become pregnant.
Study provides evidence of gut dysbiosis associated with Huntington's disease. Some of the gut measures were associated with disease symptoms such as movement and cognitive impairment. The findings could provide a new avenue of treatment for the neurodegenerative disease.
The risk of severe complications, including death, from coronavirus, is almost 50% higher in those with diabetes than the general population. Although it is yet to be verified in humans, new findings suggest diabetes may not only be a risk factor for severe COVID-19, but the infection could result in causing new onset of diabetes due to the damage it causes to pancreatic beta cells.
An FDA-approved anti-parasitic drug called Ivermectin appears to inhibit and eliminate SARS-CoV-2 in lab-grown cell cultures within 48 hours. Ivermectin shows promise as potential COVID-19 therapy. However, researchers stress the need for further testing and clinical trials in humans to confirm the effectiveness of the drug and appropriate dosage levels.
